CLL: Treatment and Management Strategies for Best Outcomes - Episode 9
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Related Content:
After 11 Years With Cancer, What Is Enough Time?
How Therapeutic Vaccines May Transform Lung Cancer Care
How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma
It’s Okay Not To Be Okay Through a Cancer Diagnosis